Scientific Publications Search Search Author Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Blankenstein, Thomas Prof. Dr. (3) Janz, Martin Dr. (7) Kammertöns, Thomas Dr. (3) Lusatis, Simone (1) Mathas, Stephan Dr. (7) Wolf, Susanne Dr. (2) (-) Daniel, Peter Prof. Dr. (1) (-) Leisegang, Matthias Prof. Dr. rer. nat. (1) (-) Uckert, Wolfgang Prof. Dr. (1) (-) Wollert-Wulf, Brigitte (2) 2002 (1) 2004 (1) (-) 2006 (4) 2007 (2) 2008 (1) 2010 (1) 2011 (3) 2013 (2) 2014 (1) 2016 (2) 2017 (1) 2018 (3) 2019 (1) 2020 (1) 2022 (1) 2023 (2) (-) Biology of Malignant Lymphomas (3) Developmental Biology / Signal Transduction (1) Genetics and Genomics of Cardiovascular Diseases (1) Mathematical Modelling of Cellular Processes (1) Microenvironmental Regulation in Autoimmunity and Cancer (1) (-) Molecular Immunology and Gene Therapy (1) Proteome Dynamics (8) Structural Biology of Membrane-Associated Processes (1) Translational Oncology of Solid Tumors (1) 4 Results: Active Filter: Daniel, Peter Prof. Dr.Leisegang, Matthias Prof. Dr. rer. nat.Uckert, Wolfgang Prof. Dr.Wollert-Wulf, BrigitteBiology of Malignant LymphomasMolecular Immunology and Gene Therapy2006 Sort: Result score Newest to oldest Oldest to newest March 15, 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou April 01, 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel February 01, 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken November 01, 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert
March 15, 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
April 01, 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel
February 01, 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
November 01, 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert